{
    "2021-11-01": [
        [
            {
                "time": "2021-11-01",
                "original_text": "Company News for Nov 1, 2021 AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Innovative Research",
                        "Rheumatology Portfolio",
                        "ACR Convergence"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "Were Hedge Funds Right About AbbVie Inc (ABBV)?",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "AbbVie Inc",
                        "ABBV"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}